Blueprint Medicines
NasdaqGS:BPMC
$ 128,18
$0,00 (0,00%)
128,18 $
$0,00 (0,00%)
End-of-day quote: 06/30/2025

Quick Analysis

This stock is no longer listed on the stock exchange.

$-3,83
Earnings Per Share
$7,96
Revenue Per Share
96,04%
Gross Margin %
$8,38 B
Market Cap
$0,54 B
Long-Term Debt
Earnings Per Share
$-3,83
Revenue Per Share
$7,96
Gross Margin %
96,04%
Market Cap
$8,38 B
Long-Term Debt
$0,54 B

Financials

Year Year 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
EPS Earnings Per Share $-3,83 $-8,37 $-9,35 $-11,01 $5,59 $-7,27 $-5,39 $-3,92 $-2,64 $-3,07
Earnings Earnings $-244,78M $-512,50M $-560,81M $-651,79M $324,00M $-392,80M $-237,70M $-171,30M $-87,65M $-83,10M
RPS Revenue Per Share $7,96 $4,07 $3,40 $3,04 $13,69 $1,23 $1,01 $0,49 $0,84 $0,42
Revenue Revenue $508,82M $249,38M $204,04M $180,08M $793,74M $66,51M $44,52M $21,43M $27,77M $11,40M
OCF Operating Cash Flow $-192,59M $-436,85M $-502,28M $-298,65M $0,00M $-278,02M $-175,01M $0,00M $-24,51M $0,00M
FCF Free Cash Flow $-197,22M $-452,91M $-511,20M $-301,74M $383,88M $-292,03M $-187,69M $-135,38M $-26,86M $0,00M
OM Operating Margin -41,67% -194,99% -263,44% 0,00% 38,89% 0,00% 0,00% 0,00% -261,33% 0,00%
GM % Gross Margin % 96,04% 94,87% 86,88% 85,71% 99,95% 100,00% 0,00% 0,00% -192,13% 0,00%
FCFS Free Cash Flow Per Share $-3,14 $-7,48 $-8,57 $-5,16 $7,04 $-6,11 $-4,28 $-3,58 $-0,98 $-2,00
LT Debt Long-Term Debt $536,58M $610,96M $535,28M N/A N/A N/A N/A N/A $1,52M $4,07M
Sha. Stocks 63,91M 61,23M 59,98M 59,2M 57,96M 54,03M 44,1M 43,7M 33,2M 27,07M
×